PCM
IPCI

Prelude Capital Management’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

Prelude Capital Management’s Portfolio IPCI Stock Details IPCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-110
Closed -$3K – 2220
2015
Q1 		$3K Buy
+110
New +$2.67K ﹤0.01% 1891

Other funds holding IPCI

TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FMBTD
First Midwest Bank Trust Division Joliet, Illinois $777M AUM 29.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
NCCM
Nine Chapters Capital Management Short Hills, New Jersey $45.4M AUM 14.43% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
RCM
Rotella Capital Management Bellevue, Washington $1.47M AUM 12.32% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

Prelude Capital Management's IPCI Position: Q2 2015 in Review

Prelude Capital Management sold out of Intellipharmaceuticals International Inc. (IPCI) in Q2 2015, closing a stake of 110 shares — an estimated $3K sold.

Prelude Capital Management first reported a position in IPCI in Q1 2015 and held it in 1 quarter. The position peaked at $3K in Q1 2015. 19 funds tracked by Wall St. Rank hold IPCI as of Q2 2015.

  • Prelude Capital Management reported no remaining Intellipharmaceuticals International Inc. position as of Q2 2015 after selling out during the quarter.
  • Prelude Capital Management sold 110 Intellipharmaceuticals International Inc. shares in Q2 2015, an estimated $3K.
  • Prelude Capital Management first reported a position in Intellipharmaceuticals International Inc. in Q1 2015 and held it in 1 quarter.
  • Prelude Capital Management's Intellipharmaceuticals International Inc. position peaked at $3K in Q1 2015.
  • 19 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q2 2015.

Based on Prelude Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.